The biological activity of the histidine-containing diketopiperazines cyclo(His-Ala) and cyclo(His-Gly)

Peptides

Volumn 27, Issue 11, 2006, Pages 2706-2714

  Lucietto, F R ^a   Milne, P J ^a   Kilian, G ^a   Frost, C L ^a   Van De Venter, M ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

Anticancer; Antimicrobial; Antithrombotic effects; Cardiac activity; Cyclo(His Ala); Cyclo(His Gly)

Indexed keywords

CYCLO(HISTIDYLALANINE); CYCLO(HISTIDYLGLYCINE); CYTOTOXIC AGENT; DIPEPTIDE DERIVATIVE; PIPERAZINEDIONE; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANDIDA ALBICANS; CELL STRAIN MCF 7; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG STRUCTURE; DRUG SYNTHESIS; FIBRIN FORMATION; HEART; HEART LEFT VENTRICLE CONTRACTION; HEART RATE; HELA CELL; HUMAN; HUMAN CELL; IC 50; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DIKETOPIPERAZINES; DRUG SCREENING ASSAYS, ANTITUMOR; HEART RATE; HISTIDINE; HUMANS; MOLECULAR STRUCTURE; PEPTIDES, CYCLIC; PIPERAZINES; PLATELET AGGREGATION; THROMBIN;

EID: 33750060089     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.04.023     Document Type: Article

References (34)

1. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48 3 (1988) 589-601
2. Anteunis M.J.O. The cyclic dipeptides: proper model compounds in peptide. Res Bull Chem Soc Belg 87 8 (1978) 627-650
3. Asche G., Kunz H., Nar H., Koppen H., Briem H., Pook K.-H., et al. Synthesis of cyclic dipeptide templates, their incorporation into peptides and studies on their conformational and biological properties. J Peptide Res 51 (1998) 323-336
4. Asin K.E., Bednarz L., Nikkel A.L., Gore Jr. P.A., Montana W.E., Cullen M.J., et al. Behavioral effects of A71623, a highly selective CCK-A agonist tetrapeptide. Am J Physiol Regul Integr Comp Physiol 263 1 (1992) R125-R135
5. Atkin C.L., and Nielands J.B. Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization. Biochemistry 7 10 (1968) 3734-3739
6. Bednar B., Condra C., Gould R.J., and Connolly T.M. Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of platelet agonists and antagonists. Thromb Res 77 5 (1995) 453-463
7. Berne R.M., and Levy M.N. Cardiovascular physiology. 5th ed. (1986), CV Mosby Company, London p. 261
8. Bhargava H.N. Modification of the characteristics of dopamine transporters in morphine tolerant and abstinent rats. Neuropharm 100 (1984) 109
9. Bodansky M. Principles of peptide synihesis. 2nd ed. (1984), Springer-Verlag, Berlin p. 201
10. Bodansky M., and Ondetti M.A. Peptide synthesis (1966), Interscience Publishers, New York p. 345
11. Brauns S.C., Milne P., Naude R., and van de Venter M. Selected cyclic dipeptides inhibit cancer cell growth and induce apoptosis in HT-29 colon cancer cells. Anticancer Res 24 3a (2004) 1713-1719
12. Capasso S., Vergara A., and Mazzarella L. Mechanism of 2,5-dioxopiperazine formation. J Am Chem Soc 120 9 (1998) 1990-1995
13. Crescenzi V., Cesaro A., and Russo E. On some physico-chemical properties of diketopiperazines in water. Int J Pept Protein Res 5 6 (1973) 427-434
14. Eloff J.N. A sensitive and quick microplate meihod to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med 64 8 (1998) 711-713
15. Goolcharran C., and Borchardt R.J. Kinetics of diketopiperazine formation using model peptides. J Pharm Sci 87 3 (1998) 283-288
16. Holden M.T., Ram C.S., de Nys R., Stead P., Bainton N.J., Hill P.J., et al. Quorum- sensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosaand other gram-negative bacteria. Mol Microbiol 33 6 (1999) 1254-1266
17. Imanishi Y., Sugihara T., Tanihara M., and Higashimura T. Facile hydrolysis of hydrophobic esters. Chem Lett (1975) 4261-4264
18. Jankowska R., and Ciarkowski J. Conformation of dioxopiperazines. Int J Pept Protein Res 30 (1987) 61-78
19. Kessler H., Wagner K., and Mill M. Analysis of peptides conformation by NMR spectroscopy. Trends Med Chem (1986) 143-157
20. Kopple K.D., and Ghazarian H.G. A convenient synthesis of 2,5-dioxopiperazines. J Org Chem 33 (1968) 862
21. Kucers A., and Bennett N.M.K. The use of antibiotics. 3rd ed. (1979), William Heinemann Medical Books Ltd., London p. 1014
22. Lee T.A. A beginner's guide id mass spectral interpretation (1998), John Wiley & Sons, USA p. 182
23. Lubbe W.F., Daries P.S., and Opie L.H. Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: a model for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovasc Res 12 4 (1978) 212-220
24. Mizuma T., Masubuchi S., and Awazu S. Intestinal absorption of stable cyclic glycylphenylalanine: comparison with the linear form. J Pharm Pharmacol 49 11 (1997) 1067-1071
25. Mizuma T., Masubuchi S., and Awazu S. Intestinal absorption of stable cyclic dipeptides by the oligopeptide transporter in rat. J Pharm Pharmacol 50 2 (1998) 167-172
26. Nierodzik M.L., Bain R.M., Liu L.X., Shivji M., Takeshita K., and Karpatkin S. Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Br J Haematol 92 2 (1996) 452-457
27. Prasad C. Bioactive cyclic dipeptides. Peptides 16 1 (1995) 151-164
28. Rob J.A., Tollefsen S., and Helgeland L.A. Rapid and highly sensitive chromogenic microplate assay for quantification of rat and human prothrombin. Anal Biochem 245 2 (1997) 222-225
29. Schatteman K.A., Goossens F.J., Scharpe S.S., and Hendriks D.F. Activation of plasma procarboxypeptidase U in different mammalian species points to a conserved pathway of inhibition offibrinolysis. Thromb Haemost 82 6 (1999) 1718-1721
30. Sheehan J.C., and McGregor D.N. Synthetic peptide models of enzyme active sites. I. Cyclo-Glycyl-l-Histafyl-l-Serylglycyl-l-Histadyl-l-Seryl. J Am Chem Soc 84 (1962) 3000
31. Sijpkes A.H., van de Kleut G.J., and Gill S.C. The solubilities of five cyclic dipeptides in water and in aqueous urea at 298.15 K: a quantitative model for the denaturation of proteins in aqueous urea solutions. Biophys Chem 52 1 (1994) 75-82
32. Thorn S.M., Horobin R.W., Seidler E., and Barer M.R. Factors affecting the selection and use of tetrazolium salts as cytochemical indicators of microbial viability and activity. J Appl Bacteriol 74 4 (1993) 433-443
33. Vicar J., Budesinsky M., and Blaha K. Amino Acids and Peptides CXIV. Proton magnetic resonance of cyclopeptides cantaining pipecolic acid, proline and/or 2-azetidine carboxylic acid. Collect Czech Chem Commun 38 (1973) 1940-1956
34. Walkowiak B., Kesy A., and Michalec L. Microplate reader: a convenient tool in studies of blood coagulation. Thromb Res 87 1 (1997) 95-103